Laparoscopic treatment of polycystic ovaries: Is its place diminishing?

Current Opinion in Obstetrics and Gynecology

Volumn 16, Issue 4, 2004, Pages 295-298

  Al Fadhli, Raedah ^a   Tulandi, Togas ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Laparoscopy; Metformin; Ovarian diathermy; Ovarian drilling; Polycystic ovary syndrome

Indexed keywords

CLOMIFENE CITRATE; METFORMIN; ANTIDIABETIC AGENT;

ATROPHY; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; LAPAROSCOPIC SURGERY; OVARY POLYCYSTIC DISEASE; OVULATION; POSTOPERATIVE COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; DRUG EFFECT; FEMALE; LAPAROSCOPY; METHODOLOGY; OVARY; PATHOLOGY; PREGNANCY;

FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; LAPAROSCOPY; METFORMIN; OVARY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE;

EID: 16544389099     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.gco.0000136495.56958.1a     Document Type: Review

References (36)

1. Gjönnaess H. Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil Steril 1984; 41:20-25.
2. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29:181-191.
3. Stein IF. Duration of infertility following ovarian wedge resection: Stein-Leventhal syndrome. West J Surg Obstet Gynecol 1964; 72:237-242.
4. Duleba A, Banaszewska B, Spaczynski R, Pawelczyk L. Success of laparoscopic ovarian wedge resection is related to obesity, lipid profile, and insulin levels. Fertil Steril 2003; 79:1008-1014.
5. Yildirim M, Noyan V, Tiras MB, et al. Ovarian wedge resection by minilaparotomy in infertile patients with polycystic ovarian syndrome: a new technique. Eur J Obstet Gynecol 2003; 107:85-87. Despite abandonment of ovarian wedge resection by others, the authors advocated this historical procedure. It is certainly not a new technique. Besides a mini-laparotomy approach, the ovarian opening was closed with chromic cat-gut. Adhesions would certainly form.
6. Portuondo JA, Melchor JC, Neyro JL, Alegre A. Periovarian adhesions following ovarian wedge resection or laparoscopic biopsy. Endoscopy 1984; 16:143-145.
7. Toaff R, Toaff ME, Peyser MR. Infertility following wedge resection of the ovaries. Am J Obstet Gynecol 1976; 124:92-96.
8. McLaughin DS. Evaluation of adhesion reformation by early second-look laparoscopy following microlaser ovarian wedge resection. Fertil Steril 1984; 42:531-537.
9. Pirwany I, Tulandi T. Laparoscopic treatment of polycystic ovaries: is it time to relinquish the procedure? Fertil Steril 2003; 80:241-251. In this comprehensive review, the authors compare the efficacy of LOD and metformin in the management of infertile women with PCOS. They found that both treatments are equally effective.
10. Tulandi T, Watkin K, Tan SL. Reproductive performance and three-dimensional ultrasound volume determination of polycystic ovaries following laparoscopic ovarian drilling. Int J Fertil Womens Med 1997; 42:36-40.
11. Fernandez H, Gervaise A, Alby JD, Kadoch J. La The place of ovarian drilling in the treatment of polycystic ovarian syndrome [La place du drilling ovarian dans la prise en change du syndrome des ovarias polykystiques]. Gynecol Obstet Fertil 2003; 31:207-213. The authors performed ovarian drilling by conventional laparoscopy and hydrolaparoscopy.
12. Amer S, Li TC, Cooke ID. A prospective dose-finding study of the amount of thermal energy required for laparoscopic ovarian diathermy. Hum Reprod 2003; 18:1693-1698.
13. Gurgan T, Urman B. Adhesions after ovarian drilling and intercede. Fertil Steril 1994; 62:424-426.
14. Saravelos H, Li TC. Post-operative adhesions after laparoscopic electrosurgical treatment for polycystic ovarian syndrome with the application of Interceed to one ovary: a prospective randomized controlled study. Hum Reprod 1996; 11:992-997.
15. Gurgan T, Kisnisci H, Yarali H, et al. Evaluation of adhesion formation after laparoscopic treatment of polycystic ovarian disease. Fertil Steril 1991; 56:1176-1178.
16. Greenblatt EM, Casper RF. Adhesion formation after laparoscopic ovarian cautery for polycystic ovarian syndrome: lack of correlation with pregnancy rate. Fertil Steril 1989; 60:766-770.
17. Dabirashrafi H. Complications of laparoscopic ovarian cauterization. Fertil Steril 1989; 52:878-879.
18. Amin AF, Abdel-Aal DE, Darwish AM, Mbeki AR. Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stoma blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome. Fertil Steril 2003; 79:938-942.
19. Parsanezhad ME, Bagheri MH, Alborzi S, Schmidt EH. Ovarian stromal blood flow changes after laparoscopic ovarian cauterization in women with polycystic ovary syndrome. Hum Reprod 2003; 18:1432-1437. LOD was found to reduce ovarian blood flow velocities. It appears that changes in Doppler parameters were higher in those who ovulated.
20. Li TC, Saravelos H, Chow MS, et al. Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br J Obstet Gynecol 1998; 105:338-344.
21. Amer SA, Li TC, Cooke ID. Repeated laparoscopic ovarian diathermy is effective in women with anovulatory infertility due to polycystic ovary syndrome. Fertil Steril 2003; 79:1211-1215. Although the sample number is small, the authors believe that repeat LOD is effective in those who previously responded to surgery. The authors did not address the possibility of decreased ovarian reserve or ovarian atrophy.
22. Felemban A, Tan SL, Tulandi T. Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal. Fertil Steril 2000; 73:266-269.
23. Amer SA, Goplan V, Li TC, et al. Long term follow up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: clinical outcome. Hum Reprod 2002; 17:2035-2042.
24. Velazquez EM, Mendoza S, Hamer T, et al. Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43:647-654.
25. Fleming R, Hopkinson ZE, Wallace AM, et al. Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial. J Clin Endocrinol Metab 2002; 87:569-574.
26. Moghetti P, Castello R, Negri C, et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85:139-146.
27. Genazzani AD, Battaglia C, Malavasi B, et al. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in non-obese patients with polycystic ovary syndrome. Fertil Steril 2004; 81:114-119. Six months of metformin treatment is associated with a spontaneous luteinizing hormone episodic release and a significant reduction in luteinizing hormone pulse amplitude. Menstrual cyclicity was restored and hirsutism score improved.
28. Maciel GA, Soares JM Jr, Motta EL, et al. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin. Fertil Steril 2004; 81:355-360. In view of serum androgen and insulin levels, nonobese women respond more favorably to metformin than obese women.
29. Pasquali R, Gambineri A, Biscotti D, et al. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85:2767-2774.
30. Nestler JE, Jakubowicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 1997; 82:4075-4079.
31. Heard MJ, Pierce A, Carson SA, Buster JE. Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome. Fertil Steril 2002; 77:669-673.
32. Batukan C, Baysal B. Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2001; 265:124-127.
33. Vandermolen DT, Ratts VS, Evans WS, et al. Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone. Fertil Steril 2001; 75:310-315.
34. Kocak M, Caliskan E, Simsir C, Haberal A. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome. Fertil Steril 2002; 77:101-106.
35. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002; 17:2858-2864.
36. Glueck CJ, Goldenberg N, Wang P, et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and the development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 2004; 19:510-521. A good prospective study on the effect of metformin in women with PCOS during pregnancy. Metformin administration throughout pregnancy may be protective against gestational diabetes.